Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Garaventa

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategiesL B Faulkner, A Garaventa, A Paoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
Bone Marrow Transplantation|November 1, 1996
Health status of long term survivors after myeloablative therapy and bone marrow transplantation in childrenL Manfredini, A Garaventa, S Barra, et al.
Bone Marrow Transplantation|November 1, 1996
Pneumopathy in children after bone marrow transplantation. Report from the AIEOP-BMT Registry. The Italian Association of Pediatric Hematology-Oncology BMT GroupA Garaventa, R Rondelli, E Castagnola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factorsA Garaventa, L Boni, M S Lo Piccolo, et al.
Bone Marrow Transplantation|July 1, 1996
Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT GroupA Garaventa, R Rondelli, E Lanino, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 23, 1998
[The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications]L B Faulkner, A Tamburini, V Tintori, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN studyJ A Kohler, H Rubie, V Castel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for NeuroblastomaA Garaventa, B De Bernardi, C Pianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 casesDe Bernardi B, C Pianca, P Pistamiglio, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategiesL B Faulkner, A Garaventa, A Paoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
Bone Marrow Transplantation|November 1, 1996
Health status of long term survivors after myeloablative therapy and bone marrow transplantation in childrenL Manfredini, A Garaventa, S Barra, et al.
Bone Marrow Transplantation|November 1, 1996
Pneumopathy in children after bone marrow transplantation. Report from the AIEOP-BMT Registry. The Italian Association of Pediatric Hematology-Oncology BMT GroupA Garaventa, R Rondelli, E Castagnola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factorsA Garaventa, L Boni, M S Lo Piccolo, et al.
Bone Marrow Transplantation|July 1, 1996
Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT GroupA Garaventa, R Rondelli, E Lanino, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 23, 1998
[The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications]L B Faulkner, A Tamburini, V Tintori, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN studyJ A Kohler, H Rubie, V Castel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for NeuroblastomaA Garaventa, B De Bernardi, C Pianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 casesDe Bernardi B, C Pianca, P Pistamiglio, et al.
Pageof 12